KELLY ALMOND: Open Payments
NPI 1679882286 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,334 in 48 payments from 16 companies in 2025. Trend: 2023 $794 · 2024 $1,441 · 2025 $1,334
Food & beverage: $1,334
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $279 |
| E.R. Squibb & Sons, L.L.C. | 13 | $192 |
| Boston Scientific Corporation | 2 | $163 |
| PFIZER INC. | 5 | $107 |
| Merck Sharp & Dohme LLC | 4 | $98 |
| Baxter Healthcare | 2 | $81 |
| Amgen Inc. | 5 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| ABIOMED | 2 | $70 |
| Abbott Laboratories | 2 | $58 |
Products named: PASCAL, CAMZYOS, WATCHMAN Access System, VYNDAQEL, Hillrom - Carnation Ambulatory Monitor, Repatha, Kerendia, VERQUVO.
Industry payments across MS — which companies pay providers there.
